According to the report published by Allied Market Research, The global Amino acid Metabolism Disorders Treatment Market size was valued at USD 630.9 million in 2021, and is projected to reach USD 961.8 million by 2031, growing at a CAGR of 4.3% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.
Increase in prevalence of amino acid metabolism disorders, rise in research and development activities on amino acid metabolism disorders treatment, and development of healthcare infrastructure drive the global amino acid metabolism disorders treatment market growth.
Request a Sample Copy of the Report: https://www.alliedmarketresearch.com/request-sample/11233
Impact of Covid-19 on Amino acid Metabolism Disorders Treatment Market-
- The Covid-19 pandemic had a negative impact on the amino acid metabolism disorders treatment market, owing to the reduced demand for amino acid metabolism disorders treatments across several sectors.
- The market faced challenges to manage the interrupted demand and supply of medical components.
- The main cause of the slowdown of the amino acid metabolism disorders treatment market growth was the interruptions experienced by the government, as it was majorly looking out for preventive measures for the disease spread during the pandemic.
Key Players of Global Amino acid Metabolism Disorders Treatment Market Report–
- AMINO GmbH
- Civentichem, LLC, Ltd.
- GlaxoSmithKline PLC
- Koninklijke DSM N.V.
- Kyowa HakkoKirin Co., Ltd.
- Merck KGaA
- Pfizer, Inc.
- Recordati S.p.A.
- Sanofi
- Shine Star (Hubei) Biological Engineering Co.
- BioMarin Pharmaceutical Inc.
- Teva Pharmaceutical Industries Ltd.
Global Amino acid Metabolism Disorders Treatment Market Segmentation: –
Based on indication, the phenylketonuria segment was the largest market in 2021, contributing to nearly half of the global amino acid metabolism disorders treatment market, and is expected to maintain its leadership status during the forecast period. This is due to the increase in prevalence of phenylketonuria and newborn screening for the diagnosis of phenylketonuria and other amino acid metabolism disorders.
Based on product, the sapropterin segment held the largest market share of more than two-fifths of the global amino acid metabolism disorders treatment market in 2021, and is expected to maintain its dominance during the forecast period. The growth is attributed to the increase in prevalence of phenylketonuria and surge in demand for sapropterin in developed countries such as the U.S. and Germany.
Based on distribution channel, the drug stores and retail pharmacies segment held the largest market share of nearly three-fifths of the global amino acid metabolism disorders treatment market in 2021, and is expected to lead the trail during the forecast period, due to the increased sales of prescription drugs and OTC drugs through drug stores and retail pharmacies.
Based on region, North America was the largest market in 2021, capturing more than two-fifths of the global amino acid metabolism disorders treatment market, and is likely to show a prominent growth during the forecast period. This is due to the increase in demand for sapropterin and kuvan for amino acid metabolism disorders treatments in the region.
By Region Outlook
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/11233
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2031?
- How big is the global & regional market in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- Which region has more opportunities?
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Details:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com